acute promyelocytic leukemia apl hematology crg page 1 acute promyelocytic leukemia apl previously untreated stanford cancer center hematology crg 26 september 2011 click here to print this page pdf please mark up a copy using black ink and fax changes to 725 9204 swogs0535 phase ii atra arsenic trioxide and gemtuzumab ozogamicin for high risk acute promyelocytic leukemia pi coutre swog pending optional path open for enrollment link trial posting observational study enrollment on hold key
